Details for 2017781429

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINATIONSTHERAPIE MIT CNP-AGONISTEN MIT GESTEUERTER FREISETZUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017781429

EP Publication Number

3518930

E-Number

1552134

Language

PCT Number

EP17074596

Publication Date

07.08.2019 A

08.03.2023 B1

Registration Date

08.03.2023

AT Publication Date

15.03.2023

Application Date

28.09.2017

Registration Number

Priorities

29.09.2016

16191456

IPC

A61K 47/60 20170101AFI20210907BHEP

Maximum Duration of Protection

28.09.2037

Owner

Ascendis Pharma Growth Disorders A/STuborg Boulevard 12 2900 HellerupDK

Representative

Dr. Müllner Dipl.-Ing. Katschinka OG, PatentanwaltskanzleiWeihburggasse 9/241010 WienAT

Inventor

HOLTEN-ANDERSEN, Larsc/o Ascendis Pharma A/S Tuborg Boulevard 12 2900 HellerupDK

MILLER BREINHOLT, Vibekec/o Ascendis Pharma A/S Tuborg Boulevard 12 2900 HellerupDK

SPROGØE, Kennettc/o Ascendis Pharma A/S Tuborg Boulevard 12 2900 HellerupDK

Information about Fees